"New visitation guidelines: Effective March 11, visitation is restricted to two persons per patient at a time, and children under the age of 18 are not permitted. Visit our website to learn more. North Shore University Hospital in Manhasset is an award winning 806-bed teaching hospital that delivers advanced care in all medical specialties, including open-heart surgery, neurosurgery, orthopaedic surgery, urology and maternal-fetal medicine."

During the past decade, Northwell Health/Center for Advanced Medicine conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 55 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 26 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health/Center for Advanced Medicine" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "NRG Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health/Center for Advanced Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health/Center for Advanced Medicine" are "Acute Myeloid Leukemia" (7 trials), "Fallopian Tube Mucinous Adenocarcinoma" (7 trials), "Ovarian Seromucinous Carcinoma" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials) and "Fallopian Tube Transitional Cell Carcinoma" (6 trials). Many other conditions were trialed in "Northwell Health/Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Northwell Health/Center for Advanced Medicine" are "Drug" (102 trials), "Other" (91 trials), "Biological" (51 trials), "Procedure" (39 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (27 trials), "Paclitaxel" (20 trials) and "Computed Tomography" (19 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health/Center for Advanced Medicine" are 88 trials for "All" genders, 32 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Northwell Health/Center for Advanced Medicine". undefined are not yet recruiting, 30 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Northwell Health/Center for Advanced Medicine, 5 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health/Center for Advanced Medicine, 4 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".